RxDoctor Payments Data

Justin Watkins, DO

Family Medicine · Brigham City, UTNPI 1780119925

Payments from drug & device makers

$2,598in general payments, 2019–2025

Across 170 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$497
  • Johnson & Johnson$290
  • Amarin Pharma, Inc.$235
  • Indivior Inc.$193
  • AstraZeneca$157
  • GSK$148
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,586100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,598 in reported general payments places this provider in the 75th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$68,447
Medicare patients
122
Services billed
952

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol70$79,770
OzempicSemaglutide42$52,464
MounjaroTirzepatide40$50,872
EliquisApixaban30$36,247
Breztri AerosphereBudesonide/Glycopyr/Formoterol46$33,617
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$26,849
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$26,664
TrulicityDulaglutide24$26,483
VraylarCariprazine Hcl14$20,432
JanuviaSitagliptin Phosphate11$16,693
QuviviqDaridorexant Hcl12$5,550
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$5,048
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen138$4,132
Testosterone Cypionate82$3,873
Dexlansoprazole DrDexlansoprazole12$3,611

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$157$113,387116 claims
Lilly USA, LLCMounjaro, Trulicity$89$77,35464 claims
Novo NordiskOzempic$59$52,46442 claims
PfizerEliquis$95$36,24730 claims
GSKTrelegy Ellipta$148$26,66425 claims
AbbVieVraylar, Synthroid$497$21,61834 claims
MerckJanuvia$18$16,69311 claims
Idorsia Pharmaceuticals US IncQuviviq$12$5,55012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 928 family medicine providers in Utah.

Other family medicine in Brigham City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →